SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Lithium Americas Corp. engages in the development of the Thacker Pass project. It is focused on advancing Thacker Pass to production it is located in northern Nevada. The company was founded on January 23, 2023 and is headquartered in Vancouver, Canada.

Lithium Americas Corp (NewCo)

Lithium Americas Corp

Lithium Americas is trending following reports of a potential equity stake from the U.S. government, sparking significant community discussion. The news is interpreted as a bullish signal, with many anticipating a short squeeze and further upside. However, some traders express caution, citing potential government shutdowns and dilution risks, while also noting the increasing number of posts by accounts with clear bullish or bearish bias.

NIKE, Inc. engages in the design, development, marketing, and sale of athletic footwear, apparel, accessories, equipment, and services. It operates through the following segments: North America, Europe, Middle East, and Africa (EMEA), Greater China, Asia Pacific and Latin America (APLA), Global Brand Divisions, Converse, and Corporate. The North America, EMEA, Greater China, and APLA segments refer to the design, development, marketing, and selling of athletic footwear, apparel, and equipment. The Global Brand Divisions segment represents its NIKE Brand licensing businesses. The Converse segment designs, markets, licenses, and sells casual sneakers, apparel, and accessories. The Corporate segment is composed of unallocated general and administrative expenses. The company was founded by William Jay Bowerman and Philip Hampson Knight on January 25, 1964 and is headquartered in Beaverton, OR.

Nike, Inc. - Ordinary Shares - Class B

Nike Inc

Nike is trending as investors discuss the potential impact of earnings, with some pointing to revenue growth and others highlighting margin concerns and the upcoming guidance. Community members are also weighing in on the brand's relevance and innovation, along with the potential of the new SKIMS collaboration to drive growth in the women's activewear market. Some traders anticipate a volatile swing post-earnings release, while others are focusing on long-term potential.

Mannatech, Inc. engages in the development of nutritional supplements, topical and skin care products and weight-management products that target optimal health and wellness. Its product category includes integrative health, targeted health, wealth and fitness, skin care, essentials, and home. The company was founded by Marlin Ray Robbins and Samuel L. Caster in November 1993 and is headquartered in Flower Mound, TX.

Mannatech Inc

MTEX is trending due to its low float and the potential for a significant squeeze, with the community actively discussing potential breakouts and short positions. Recent spikes toward a specific price point have captured attention, and some traders are comparing it to other stocks that have experienced similar rapid gains. Some are pointing to a low float and thin order book as reasons for a potential parabolic move.

DraftKings, Inc. is a digital sports entertainment and gaming company, which engages in the provision of online sports betting, online casino, daily fantasy sports product offerings, DraftKings Marketplace, retail sportsbook, media, and other consumer product offerings. The company was founded by Jason D. Robins, Matthew Kalish, and Paul Liberman on December 31, 2011 and is headquartered in Boston, MA.

DraftKings Inc. - Ordinary Shares - Class A

DraftKings Inc

DKNG is trending due to concerns about increasing competition from prediction markets like Kalshi and Robinhood, which are seeing high trading volumes, especially in states where sports betting is not yet legal. The community is debating whether these platforms pose a significant threat to DraftKings' market share, and some express frustration with the company's management and perceived lack of innovation in response to this evolving landscape. Despite partnerships, some investors believe DraftKings needs to actively participate in the prediction market space.

"What's Updog?" is a Community Led token.

UpDog

UpDog ($UPDOG.X) is trending as the community rallies around the long-standing joke and continues to build on the Solana blockchain. Many are highlighting the opportunity to become an UpDog millionaire and are swapping $SOL for $UPDOG.X. Community members are also actively collaborating and congratulating each other on trending.

Solana is a highly functional open source project that banks on blockchain technology’s permissionless nature to provide decentralized finance (DeFi) solutions. It is a layer 1 network that offers fast speeds and affordable costs. While the idea and initial work on the project began in 2017, Solana was officially launched in March 2020 by the Solana Foundation with headquarters in Geneva, Switzerland.

Solana

Solana is trending as the community discusses potential ETF approvals and increased inflows into the Solana ecosystem. There is also buzz around meme coins built on Solana, such as $UPDOG.X, $AKIRA.X, and $WAGMI.X, with many users highlighting these as opportunities and promoting community engagement.

Draganfly, Inc. engages in the manufacture and sale of commercial unmanned aerial vehicle systems and software serving the public safety, agriculture, industrial inspections, security, mapping, and surveying markets. Its products include quad-copters, fixed wing aircrafts, ground based robots, hand held controllers, and software used for tracking, live streaming, and data collection. The firm also offers custom engineering, training, simulation consulting, as well as data and flight training services. The company was founded by Zenon Dragan and Christine Dragan in 1998 and is headquartered in Saskatoon, Canada.

Draganfly Inc

Draganfly Inc (DPRO) is trending as traders discuss its recent surge following news of a U.S. Army deal to supply drone systems, though the financial details remain undisclosed. The community is focused on the potential for a short squeeze, with some speculating about future contract details and comparing DPRO's market cap to sector peers. Bullish sentiment suggests anticipation for further gains, while others caution about potential offerings.

BrokeCoin is a meme-meets-utility cryptocurrency project operating under the ethos of Transparency, Community, and Respect. Formally registered as an LLC in Wyoming, USA, BrokeCoin is building an expansive ecosystem that combines light-hearted spirit of meme culture with real-world crypto utilities—spanning gaming, staking, NFTs, web services, and an e-commerce platform. Brokecoin believes in developing useful and interesting meme-inspired utilities to both service the crypto industry, and generate value for holders.

Brokecoin

Brokecoin is trending as the community rallies to reach the next watcher milestone, anticipating a token burn event. Community members highlight the active development team, staking utility, and the project's strong presence within the Solana ecosystem. The conversation also centers around accumulating $BROKE and swapping other tokens for it.

PayPal Holdings, Inc. engages in the development of technology platforms that enable digital payments and simplifies commerce experiences on behalf of merchants and consumers worldwide. Its solutions include PayPal, PayPal Credit, Braintree, Venmo, Xoom, and Paydiant products. The firm also enables consumers to exchange funds with merchants using funding sources, which include bank account, PayPal account balance, PayPal Credit account, credit, and debit card or other stored value products. It operates through United States and Other Countries geographical segments. The company was founded in December 1998 and is headquartered in San Jose, CA.

PayPal Holdings Inc

PayPal ($PYPL) is experiencing significant volatility, with community discussions focusing on a recent sharp decline despite positive news and a Google partnership; some speculate about market manipulation and potential for a short squeeze. Community members express frustration with the stock's inability to sustain gains, while others remain optimistic about buybacks, growth initiatives, and a potential takeover. Overall, sentiment is mixed, with some seeing a value opportunity and others expressing deep disappointment.

Top Wealth Group Holding Ltd. operates as a holding company, which provides caviar and caviar-based gourmet products. It focuses on supplying sturgeon caviar to customers under its own brand, Imperial Cristal Caviar. The company was founded by Kim Kwan Kings Wong on February 1, 2023 and is headquartered in Hong Kong.

Top Wealth Group Holding Ltd. - Ordinary Shares - Class A

Top Wealth Group Holding Ltd.

TWG is trending due to discussions around its low float and potential for a short squeeze, with some traders drawing comparisons to other stocks with similar setups. Community members are also analyzing the company's financials, particularly its earnings report, for insights on future performance. Recent price action and after-hours gains have further fueled interest in the stock.

statis crypto Watchlist

Bitcoin

Ethereum

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$NVAX I’m hopeful for a September approval for Novavax, but I’m also very untrusting of FDA. Suppose they approve both Pfizer and Moderna, but delay us like last time. I’m sure the hit-pieces claiming “Novavax again has production problems” will come within minutes. Is thit going to be another -50% day?
I’m just having a hard time believing the bullshit games could really come to an end.

Paolo

Demetrio

Mark Mattola

thomas McNamara

Fernando Czerwinski

StockTwits for iOS

Novavax Inc

 I’m hopeful for a September approval for Novavax, but I’m also very untrusting of FDA. Suppose they approve both Pfizer and Moderna, but delay us like last time. I’m sure the hit-pieces claiming “Novavax again has production problems” will come within minutes. Is thit going to be another -50% day?
I’m just having a hard time believing the bullshit games could really come to an end.

Brian Anderson

@OneDollarBob I also hope but unfortunately won&#39;t be surprised if history repeats itself again! it may very well be so! we then witness history in that both company leaders did exactly the same mistakes repeatedly!! Promised a lot delivered nothing! let&#39;s pray this doesn&#39;t happen but JJ is a man of his word and delivers.

 I also hope but unfortunately won't be surprised if history repeats itself again! it may very well be so! we then witness history in that both company leaders did exactly the same mistakes repeatedly!! Promised a lot delivered nothing! let's pray this doesn't happen but JJ is a man of his word and delivers.

@JN25 The news out of Canada is concerning. How do they already know that Novavax will be delayed? Why are they still saying that “the Novavax vaccine is for those who are unwilling or unable to get an mRNA vaccine”? I imagine they’ll keep saying that the mRNA vaccines are “preferred” as well. The average person who is willing to get the vaccine is just going to take what the government recommends, even if it’s bullshit. If they say “mRNA vaccines are preferred”, that’s what most people are going to get. Doesn’t really matter that they don’t work and have a laundry list of side effects.
This all feels too familiar. Stan was “in constant communication with FDA” as well JJ. Hope you’re paying attention.

 The news out of Canada is concerning. How do they already know that Novavax will be delayed? Why are they still saying that “the Novavax vaccine is for those who are unwilling or unable to get an mRNA vaccine”? I imagine they’ll keep saying that the mRNA vaccines are “preferred” as well. The average person who is willing to get the vaccine is just going to take what the government recommends, even if it’s bullshit. If they say “mRNA vaccines are preferred”, that’s what most people are going to get. Doesn’t really matter that they don’t work and have a laundry list of side effects.
This all feels too familiar. Stan was “in constant communication with FDA” as well JJ. Hope you’re paying attention.

@OneDollarBob  CDC is agreeing with their studies

StockTwits For Android 

Frankie Smilez

@OneDollarBob  JJ and his team must have done thorough evaluations of why Stan failed and do everything they can to not repeat the same mistakes! Feels risky and feels worrying that history is repeating itself again.

  JJ and his team must have done thorough evaluations of why Stan failed and do everything they can to not repeat the same mistakes! Feels risky and feels worrying that history is repeating itself again.

@OneDollarBob Problem is they’re not effectively communicating with investing communities. They’ve been producing batches of 6K for XBB 1.5 &amp; 1.6 in Q1 based on what Filip said in Q1 ER call. Also BioLogics is fully functional &amp; got its certification in April ( leading to $350 m renegotiation of previous contracts.) As far as USFDA, Estimated/projected US revenue for 2023 is so ridiculously low that I seriously think we’re better off shifting revenue objectives if slow walking golden standard is only applied to Novavax for obvious reasons.

 Problem is they’re not effectively communicating with investing communities. They’ve been producing batches of 6K for XBB 1.5 & 1.6 in Q1 based on what Filip said in Q1 ER call. Also BioLogics is fully functional & got its certification in April ( leading to $350 m renegotiation of previous contracts.) As far as USFDA, Estimated/projected US revenue for 2023 is so ridiculously low that I seriously think we’re better off shifting revenue objectives if slow walking golden standard is only applied to Novavax for obvious reasons.

Sammy Leonidas

@DrSammy I agree with everything you’re saying, but if production is going so smoothly (and I think that it is) what’s the deal with Canada?

 I agree with everything you’re saying, but if production is going so smoothly (and I think that it is) what’s the deal with Canada?

@OneDollarBob imo, this new agreement/arrangement is a positive sign &amp; Canadian government is 100 % behind it. They have made substantial investment in BioLogics &amp; I’m sure they are as excited as we are to move forward w/ fall deployments! But we don’t what’s really going on &amp; their silence leads to speculation

Henry Tyroon

DarvasBoxing

 imo, this new agreement/arrangement is a positive sign & Canadian government is 100 % behind it. They have made substantial investment in BioLogics & I’m sure they are as excited as we are to move forward w/ fall deployments! But we don’t what’s really going on & their silence leads to speculation

@OneDollarBob if Nova enters the market unrestricted, there’s no way, at least cost wise, they can compete with it in private markets.

 if Nova enters the market unrestricted, there’s no way, at least cost wise, they can compete with it in private markets.

@TomMac64 Well, I suppose that is possible? But, since they’re partnered with the world’s largest vaccine producer…and protein vaccines have been produced for decades, I’m hoping that’s not the case.

 Well, I suppose that is possible? But, since they’re partnered with the world’s largest vaccine producer…and protein vaccines have been produced for decades, I’m hoping that’s not the case.